Where the Comment is King

THE NEWS COMMENTER

VOTE  (0)  (0)

J&J Covid-19 vaccine data due 'soon' as drug maker boosts outlook

Added 01-26-21 10:04:03am EST - “The world's biggest maker of health care products topped profit and sales expectations.” - Foxbusiness.com

CLICK TO SHARE

Posted By TheNewsCommenter: From Foxbusiness.com: “J&J Covid-19 vaccine data due 'soon' as drug maker boosts outlook”. Below is an excerpt from the article.

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by Refinitiv Lipper.

This material may not be published, broadcast, rewritten, or redistributed. ©2021 FOX News Network, LLC. All rights reserved. FAQ - Updated Privacy Policy

Johnson & Johnson CEO Alex Gorsky announced Tuesday that the details of its Phase 3 coronavirus study will be released 'soon' -- while also boosting the company's profit goals for the coming year.

The pharmaceutical giant has been developing and testing Janssen’s experimental COVID-19 vaccine candidate, which is in Phase 3 of its clinical trials, in an effort to help eradicate the pandemic that has already infected more than 99 million people worldwide.

"We continue to progress our COVID-19 vaccine candidate and look forward to sharing details from our Phase 3 study soon," Gorsky said in the company's fourth-quarter and full-year earnings report.

Read more...

If you don't see any comments yet, congrats! You get first comment. Be nice and have fun.

CLICK TO SHARE

BACK TO THE HOME-PAGE